首页 > 市场调查报告书 > 医疗设备

药物递输设备呼吸器

市场调查报告书

商品编码

1970625

全球雾化器市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Nebuliser Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: 2026年02月05日 | 出版商:

Value Market Research | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

预计雾化器市场将从 2025 年的 14.3 亿美元成长到 2034 年的 26.4 亿美元，2026 年至 2034 年的复合年增长率为 7.02%。

由于气喘、慢性阻塞性肺病（COPD）和慢性支气管炎等呼吸系统疾病的日益普遍，雾化器市场正在不断扩张。这些设备可以将液体药物转化为可直接吸入的雾状液体，从而实现快速有效的药物输送。人口老化和呼吸系统健康意识的提高正在推动雾化器在全球范围内的普及。

技术进步促使雾化器朝向携带式、电池供电的筛孔式喷雾器发展，提高了效率和便利性。与数位平台整合后，可以远端监测吸入模式并追踪治疗依从性。製造商也致力于研发更安静、更紧凑的设计，以提高患者的依从性。

居家医疗基础设施的扩张、污染水平的上升以及都市区呼吸系统疾病发病率的增加，预计将推动市场成长。雾化器凭藉其易用性、精准性和以患者为中心的创新理念，将继续成为呼吸系统治疗中不可或缺的工具。

区域分析
北美市场分析、洞察与预测
- 我们
- 加拿大
- 墨西哥
欧洲市场分析、洞察与预测
- 英国
- 法国
- 德国
- 义大利
- 俄罗斯
- 其他欧洲国家
亚太市场分析、洞察与预测
- 印度
- 日本
- 韩国
- 澳洲
- 东南亚
- 其他亚太国家
拉丁美洲市场分析、洞察与预测
- 巴西
- 阿根廷
- 秘鲁
- 智利
- 其他拉丁美洲国家
中东和非洲市场分析、洞察与预测
- 沙乌地阿拉伯
- UAE
- 以色列
- 南非
- 其他中东和非洲国家

第八章竞争情势

最新趋势
公司分类
供应链和销售管道合作伙伴（根据现有资讯）
市场占有率和市场定位分析（基于现有资讯）
供应商情况（基于现有资讯）
策略规划

第九章：公司简介

主要公司的市占率分析
公司简介
- Omron Corporation
- GE Healthcare
- Koninklijke Philips NV
- Vectura Group Plc
- PARI Respiratory Equipment Inc
- Aerogen
- DeVilbiss Healthcare LLC
- Beurer GmbH
- Microlife Corporation
- GF Health Products Inc
- Rossmax International Ltd
- BESCO MEDICAL LIMITED
- Bremed Ltd

简介目录

Product Code: VMR11219848

The Nebuliser Market size is expected to reach USD 2.64 Billion in 2034 from USD 1.43 Billion (2025) growing at a CAGR of 7.02% during 2026-2034.

The nebuliser market is expanding due to rising prevalence of respiratory conditions such as asthma, COPD, and chronic bronchitis. These devices convert liquid medication into mist for direct inhalation, offering fast and effective drug delivery. Increasing geriatric populations and heightened awareness of respiratory health are fueling adoption worldwide.

Technological innovation is driving the transition toward portable, battery-operated, and mesh nebulisers that offer improved efficiency and convenience. Integration with digital platforms allows for remote monitoring of inhalation patterns and treatment adherence. Manufacturers are also focusing on quieter, more compact designs that enhance patient compliance.

The market will benefit from expanding home healthcare infrastructure, rising pollution levels, and increasing prevalence of respiratory disorders in urban populations. Nebulisers are set to remain integral to respiratory therapeutics, combining ease of use, precision, and patient-centric innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

Jet
Mesh (Active, Passive)
Ultrasonic

By Application

COPD
Cystic Fibrosis
Asthma
Others

By End-use

Hospital And Clinics
Emergency Centers
Home Healthcare

COMPANIES PROFILED

Omron Corporation, GE Healthcare, Koninklijke Philips NV, Vectura Group Plc, PARI Respiratory Equipment Inc, Aerogen, DeVilbiss Healthcare LLC, Beurer GmbH, Microlife Corporation, GF Health Products Inc, Rossmax International Ltd, BESCO MEDICAL LIMITED, Bremed Ltd
We can customise the report as per your requirements.

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL NEBULISER MARKET: BY TYPE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Type
4.2. Jet Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Mesh (Active, Passive) Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Ultrasonic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEBULISER MARKET: BY APPLICATION 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Application
5.2. COPD Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Cystic Fibrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEBULISER MARKET: BY END-USE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast End-use
6.2. Hospital And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Emergency Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Home Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEBULISER MARKET: BY REGION 2022-2034(USD MN)

7.1. Regional Outlook
7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Type
- 7.2.2 By Application
- 7.2.3 By End-use
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Type
- 7.3.2 By Application
- 7.3.3 By End-use
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Type
- 7.4.2 By Application
- 7.4.3 By End-use
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Type
- 7.5.2 By Application
- 7.5.3 By End-use
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Type
- 7.6.2 By Application
- 7.6.3 By End-use
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

8.1. Recent Developments
8.2. Company Categorization
8.3. Supply Chain & Channel Partners (based on availability)
8.4. Market Share & Positioning Analysis (based on availability)
8.5. Vendor Landscape (based on availability)
8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEBULISER INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Company Profiles
- 9.2.1 Omron Corporation
- 9.2.2 GE Healthcare
- 9.2.3 Koninklijke Philips N.V
- 9.2.4 Vectura Group Plc
- 9.2.5 PARI Respiratory Equipment Inc
- 9.2.6 Aerogen
- 9.2.7 DeVilbiss Healthcare LLC
- 9.2.8 Beurer GmbH
- 9.2.9 Microlife Corporation
- 9.2.10 GF Health Products Inc
- 9.2.11 Rossmax International Ltd
- 9.2.12 BESCO MEDICAL LIMITED
- 9.2.13 Bremed Ltd

02-2729-4219

+886-2-2729-4219

License/价格

全球雾化器市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Nebuliser Market Size, Share, Trends & Growth Analysis Report 2026-2034